Royal Bank of Canada’s Cascadian Therapeutics, Inc. CASC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q1 | – | Sell |
-732
| Closed | -$2K | – | 6313 |
|
|
2017
Q4 | $2K | Sell |
732
-3,355
| -82% | -$9.17K | ﹤0.01% | 5578 |
|
|
2017
Q3 | $17K | Buy |
4,087
+2,983
| +270% | +$12.4K | ﹤0.01% | 5296 |
|
|
2017
Q2 | $3K | Buy |
1,104
+94
| +9% | +$255 | ﹤0.01% | 5472 |
|
|
2017
Q1 | $4K | Buy |
1,010
+4
| +0.4% | +$16 | ﹤0.01% | 5629 |
|
|
2016
Q4 | $4K | Hold |
1,006
| – | – | ﹤0.01% | 5614 |
|
|
2016
Q3 | $10K | Hold |
1,006
| – | – | ﹤0.01% | 5036 |
|
|
2016
Q2 | $6K | Hold |
1,006
| – | – | ﹤0.01% | 5205 |
|
|
2016
Q1 | $8K | Buy |
1,006
+653
| +185% | +$5.19K | ﹤0.01% | 5112 |
|
|
2015
Q4 | $5K | Sell |
353
-1,005
| -74% | -$14.2K | ﹤0.01% | 5414 |
|
|
2015
Q3 | $22K | Sell |
1,358
-174
| -11% | -$2.82K | ﹤0.01% | 4947 |
|
|
2015
Q2 | $34K | Buy |
1,532
+1,157
| +309% | +$25.7K | ﹤0.01% | 4940 |
|
|
2015
Q1 | $4K | Hold |
375
| – | – | ﹤0.01% | 5363 |
|
|
2014
Q4 | $4K | Buy |
375
+28
| +8% | +$299 | ﹤0.01% | 5283 |
|
|
2014
Q3 | $4K | Hold |
347
| – | – | ﹤0.01% | 5145 |
|
|
2014
Q2 | $6K | Buy |
347
+339
| +4,238% | +$5.86K | ﹤0.01% | 5030 |
|
|
2014
Q1 | $0 | Sell |
8
-56
| -88% | – | ﹤0.01% | 5525 |
|
|
2013
Q4 | $1K | Buy |
64
+53
| +482% | +$828 | ﹤0.01% | 5203 |
|
|
2013
Q3 | $0 | Hold |
11
| – | – | ﹤0.01% | 5670 |
|
|
2013
Q2 | $0 | Buy |
+11
| New | – | ﹤0.01% | 5271 |
|